Benadryl
Metastases
Merck Sharp & Dohme LLCPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Metastases cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Denosumab Ottawa Hospital Research Institute | Phase 4 | BB |
DACARBAZINE AstraZeneca | Phase 3 | BB |
Ixabepilone Nektar Therapeutics | Phase 3 | BB |
Hycamtin Eli Lilly and Company | Phase 3 | BB |
Trebananib Amgen | Phase 2 | BB |
View all 32 →
Same molecule, other indications
Benadryl is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →